More Books:

Immunopharmacology of Infectious Diseases
Language: en
Pages: 359
Authors: Jeannine A. Majde
Categories: Antigens
Type: BOOK - Published: 1987 - Publisher:

Books about Immunopharmacology of Infectious Diseases
Immunopharmacology of Infectious Diseases
Language: en
Pages: 386
Authors: Jeannine A. Majde
Categories: Medical
Type: BOOK - Published: 1987-11-01 - Publisher: Wiley-Liss

Presenting recent advances in worldwide research into the prophylaxis and therapy of infectious disease, this work offers a comprehensive analysis of structure-function aspects of vaccine adjuvant research. Its primary focus is on new data on host defense machanisms and the drugs that modulate them, including some compounds never before discussed
Novel Immunologic Adjuvants
Language: en
Pages: 111
Authors: Rino Rappuoli, Ennio De Gregorio
Categories: Electronic books
Type: BOOK - Published: 2011-10 - Publisher: Future Medicine Ltd

The study of adjuvants substances added to vaccine formulations to increase efficacy is one of the fastest growing disciplines in immunology and vaccine development. This book reviews the state-of-the-art of development of novel adjuvants and the science that supports them. There is an increasing need of novel adjuvants for preventive
Vaccine Adjuvants
Language: en
Pages: 284
Authors: Charles J. Hackett, Donald A. Harn Jr
Categories: Medical
Type: BOOK - Published: 2007-11-05 - Publisher: Springer Science & Business Media

A cutting-edge review of the major research areas of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand
Vaccine Design
Language: en
Pages: 949
Authors: Michael F. Powell, Mark J. Newman
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer

When my interest was first drawn to the phenomenon of vaccination for virus diseases in the late 1930s, the state of the art and the science of vaccine design was not far advanced beyond the time of Jenner at the end of the 18th century and of Pasteur a century